NCT04475380View on ClinicalTrials.gov

Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents

UnknownOBSERVATIONAL
Enrollment

1,757

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2025

Conditions
Acute Coronary SyndromeAngina PectorisAngina, UnstableMyocardial InfarctionCoronary Artery DiseaseCoronary StenosisCoronary Restenosis
Interventions
DEVICE

Percutaneous coronary intervention

PCI for treatment of coronary or bypass graft lesions

Trial Locations (2)

Unknown

Thoraxcentrum Twente, Enschede

Haga Ziekenhuis, The Hague

Sponsors

Collaborators (1)

Abbott Medical Devices
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

Foundation of Cardiovascular Research and Education Enschede

OTHER

NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents | Biotech Hunter | Biotech Hunter